What is a condition under which a practitioner can provide controlled substances via infusion in a home or hospice setting according to reporting regulations?

In a home or hospice setting, practitioners can provide controlled substances through infusion primarily for the purpose of patient care and management of symptoms, such as pain relief. The reporting regulations are designed to ensure that controlled substances are used safely and in compliance with legal standards.

The option regarding controlled substances administered via infusion directly addresses the regulatory framework that dictates how these medications can be managed when provided in settings outside of traditional healthcare facilities. This aligns with the necessary provisions to support ongoing care for patients with serious health conditions, facilitating the use of effective pain management strategies while adhering to appropriate monitoring and record-keeping.

The other options do not address the specific scenario of controlled substances being administered via infusion in a home or hospice setting. Medications approved by the FDA, medications under clinical trials, and medications classified as non-narcotics do not fall within the specific regulatory requirements for controlled substances, which focus on their safe distribution and administration, especially when it comes to infusion methods.